321 related articles for article (PubMed ID: 30684677)
1. Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
Kawamura M; Sato S; Matsumoto G; Fukuda T; Shiba-Fukushima K; Noda S; Takanashi M; Mori N; Hattori N
Neurosci Lett; 2019 Apr; 699():59-63. PubMed ID: 30684677
[TBL] [Abstract][Full Text] [Related]
2. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
3. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Grochowska MM; Carreras Mascaro A; Boumeester V; Natale D; Breedveld GJ; Geut H; van Cappellen WA; Boon AJW; Kievit AJA; Sammler E; ; Parchi P; Cortelli P; Alessi DR; van de Berg WDJ; Bonifati V; Mandemakers W
Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity.
Pajarillo E; Rizor A; Son DS; Aschner M; Lee E
J Biol Chem; 2020 Mar; 295(10):3040-3054. PubMed ID: 32001620
[TBL] [Abstract][Full Text] [Related]
5. REST and stress resistance in ageing and Alzheimer's disease.
Lu T; Aron L; Zullo J; Pan Y; Kim H; Chen Y; Yang TH; Kim HM; Drake D; Liu XS; Bennett DA; Colaiácovo MP; Yankner BA
Nature; 2014 Mar; 507(7493):448-54. PubMed ID: 24670762
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
7. Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson's disease.
Huang D; Li Q; Wang Y; Liu Z; Wang Z; Li H; Wang J; Su J; Ma Y; Yu M; Fei J; Huang F
Aging (Albany NY); 2019 May; 11(10):3280-3297. PubMed ID: 31147527
[TBL] [Abstract][Full Text] [Related]
8. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders.
Patterson L; Rushton SP; Attems J; Thomas AJ; Morris CM
Brain Pathol; 2019 Jul; 29(4):544-557. PubMed ID: 30582885
[TBL] [Abstract][Full Text] [Related]
9. Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
Ikeda-Matsuo Y; Miyata H; Mizoguchi T; Ohama E; Naito Y; Uematsu S; Akira S; Sasaki Y; Tanabe M
Neurobiol Dis; 2019 Apr; 124():81-92. PubMed ID: 30423474
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
11. Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies.
Ferrer I; Gómez A; Carmona M; Huesa G; Porta S; Riera-Codina M; Biagioli M; Gustincich S; Aso E
J Alzheimers Dis; 2011; 23(3):537-50. PubMed ID: 21157025
[TBL] [Abstract][Full Text] [Related]
12. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
Schulz-Schaeffer WJ
Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Kawamoto Y; Ito H; Ayaki T; Takahashi R
Brain Res; 2014 Jul; 1571():39-48. PubMed ID: 24835407
[TBL] [Abstract][Full Text] [Related]
14. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
15. NRSF/REST neuronal deficient mice are more vulnerable to the neurotoxin MPTP.
Yu M; Suo H; Liu M; Cai L; Liu J; Huang Y; Xu J; Wang Y; Zhu C; Fei J; Huang F
Neurobiol Aging; 2013 Mar; 34(3):916-27. PubMed ID: 22766071
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
[TBL] [Abstract][Full Text] [Related]
17. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor kappa-B p50 and p65 subunits expression in dementia with Lewy bodies.
Saldaña M; Mullol J; Aguilar E; Bonastre M; Marin C
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):308-16. PubMed ID: 17442064
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
20. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
